Inventor · disambiguated record
Scott Schaus
Also filed as: SCHAUS SCOTT · SCHAUS SCOTT E · SCHAUS SCOTT EDWARD
16 granted patents·3 pending applications·71 citations·filing 1998–2023
89Inventor score
Top patents by PatentIndex Score
19 records- 0188US6130340AAsymmetric cycloaddition reactionsHARVARD COLLEGE·Filed 1998·Granted Oct 10, 2000·47 cites·69 claims
- 0283US9815845B2Inhibitors of late SV40 factor (LSF) as cancer chemotherapeuticsUNIV BOSTON·Filed 2016·Granted Nov 14, 2017·4 cites·14 claims
- 0382US9802948B2Inhibitors of late SV40 factor (LSF) as cancer chemotherapeuticsUNIV BOSTON·Filed 2016·Granted Oct 31, 2017·4 cites·7 claims
- 0469US6211370B1Asymmetric cycloaddition reactionsHARVARD COLLEGE·Filed 1999·Granted Apr 3, 2001·12 cites·52 claims
- 0565US10314810B2Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeuticsSHERR DAVID H·Filed 2011·Granted Jun 11, 2019·3 cites·4 claims
- 0660US11420977B2Late SV40 (LSF) inhibitorsUNIV BOSTON·Filed 2019·Granted Aug 23, 2022·0 cites·5 claims
- 0759US6369223B2Asymmetric cycloaddition reactionsHARVARD COLLEGE·Filed 2001·Granted Apr 9, 2002·1 cites·28 claims
- 0857US9175001B2[1,3] dioxolo [4,5-g] [1,2,4] triazolo [1,5-a] quinoline derivatives as inhibitors of the late SV40 factor (LSF) for use in treating cancerUNIV BOSTON·Filed 2012·Granted Nov 3, 2015·0 cites·10 claims
- 0956US2022112206A1Heterocyclic lsf inhibitors and their usesUNIV BOSTON·Filed 2021·Application pending·0 cites
- 1055US11242353B2Heterocyclic LSF inhibitors and their usesUNIV BOSTON·Filed 2021·Granted Feb 8, 2022·0 cites·30 claims
- 1155US10392398B2Inhibitors of Late SV40 Factor (LSF) as cancer chemotherapeuticsUNIV BOSTON·Filed 2017·Granted Aug 27, 2019·0 cites·14 claims
- 1254US12251372B2Antileishmanial compounds, compositions and use thereofUNIV BOSTON·Filed 2023·Granted Mar 18, 2025·0 cites·23 claims
- 1354US9567331B2Pyridopyrimidinone inhibitors of virusesUNIV BOSTON·Filed 2012·Granted Feb 14, 2017·0 cites·15 claims
- 1453US2024011990A1Viral detection systems and uses thereofUNIV BOSTON·Filed 2021·Application pending·0 cites
- 1552US9399644B2[1,3] dioxolo [4,5-G] quinoline-6(5H)thione derivatives as inhibitors of the late SV40 factor (LSF) for use in treating cancerUNIV BOSTON·Filed 2015·Granted Jul 26, 2016·0 cites·10 claims
- 1650US11458132B2Quinolin-2(1H)-one inhibitors of Late SV40 FactorUNIV BOSTON·Filed 2021·Granted Oct 4, 2022·0 cites·28 claims
- 1747US2010234348A1Compositions and methods for potentiating antibiotic activityUNIV BOSTON·Filed 2007·Application pending·0 cites
- 1844US10258600B2Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeuticsUNIV BOSTON·Filed 2016·Granted Apr 16, 2019·0 cites·7 claims
- 1929US9597325B2Inhibitors of late SV40 factor (LSF) as cancer chemotherapeuticsHANSEN ULLA·Filed 2011·Granted Mar 21, 2017·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Scott Schaus files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →